Step Monitoring to Improve ARTERial Health

NACompletedINTERVENTIONAL
Enrollment

347

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Type 2 DiabetesHypertension
Interventions
BEHAVIORAL

Step count prescription

Treating physicians will provide a pedometer, pedometer log, and step count prescription. The aim is a net increase of at least 3,000 steps/day over one year. The time frame for this increase will be 10 months for sedentary participants (\<5,000 steps/day), 7 months for low active participants (5,000-7,499 steps/day), and 5 months for somewhat active participants (7,500-9,999 steps/day). If goals are not met, the doctor and participant will review barriers and facilitators, and a more individualized prescription will be formulated (e.g. lower incremental step count targets or slower rate of dose escalation). For participants who meet goals, the doctor and participant will together decide whether to aim for a further increase.

BEHAVIORAL

Usual care

The control trial arm will receive usual care alone, over a one-year period (i.e. no step count prescription but, in accordance with guidelines, including advice to engage in 30-60 minutes of activity on most days of the week).

Trial Locations (6)

H2W 1R7

Institut de recherches cliniques de Montréal, Montreal

H3A 1A1

McGill University Health Centre - Royal Victoria Hosptial, Montreal

H3G 1A4

McGill University Health Centre - Montreal General Hospital, Montreal

H3T 1E2

Jewish General Hospital, Montreal

H3T 1M5

St. Mary's Hospital Center, Montreal

H9R 2Y2

Lakeshore General Hospital, Montreal

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

lead

McGill University Health Centre/Research Institute of the McGill University Health Centre

OTHER

NCT01475201 - Step Monitoring to Improve ARTERial Health | Biotech Hunter | Biotech Hunter